Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome.
BACKGROUND
Biomarker-based assessments of biological samples are widespread in clinical, pre-clinical, and epidemiological investigations. We previously developed serum metabolomic profiles assessed by HPLC-separations coupled with coulometric array detection that can accurately identify ad libitum fed and caloric-restricted rats. These profiles are being adapted for human epidemiology studies, given the importance of energy balance in human disease.


METHODS
Human plasma samples were biochemically analyzed using HPLC separations coupled with coulometric electrode array detection.


RESULTS
We identified these markers/metabolites in human plasma, and then used them to determine which human samples represent blinded duplicates with 100% accuracy (N = 30 of 30). At least 47 of 61 metabolites tested were sufficiently stable for use even after 48 hours of exposure to shipping conditions. Stability of some metabolites differed between individuals (N = 10 at 0, 24, and 48 hours), suggesting the influence of some biological factors on parameters normally considered as analytical.


CONCLUSIONS
Overall analytical precision (mean median CV, ~9%) and total between-person variation (median CV, ~50-70%) appear well suited to enable use of metabolomics markers in human clinical trials and epidemiological studies, including studies of the effect of caloric intake and balance on long-term cancer risk.
Shurubor
Yevgeniya I
YI
Department of Neurosurgery, Brigham and Women's Hospital, 221 Longwood Ave, LM322B, Boston, MA 02115, USA. yshurubo@gmail.com
Matson
Wayne R
WR
Willett
Walter C
WC
Hankinson
Susan E
SE
Kristal
Bruce S
BS